Effects of Upper Extremity Rehabilitation Robot and Transcranial Direct Current Stimulation in Chronic Stroke

Sponsor
National Rehabilitation Center, Seoul, Korea (Other)
Overall Status
Unknown status
CT.gov ID
NCT04005131
Collaborator
(none)
20
1
2
20
1

Study Details

Study Description

Brief Summary

Comparison of real transcranial direct current stimulation (tDCS) and sham tDCS combined with robot training for upper extremity rehabilitation in subjects with chronic stroke - delayed start study.

Condition or Disease Intervention/Treatment Phase
  • Device: Robot and tDCS on-line
  • Device: Robot and tDCS on-line after sham tDCS
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Masking Description:
Participant does not know the allocation.
Primary Purpose:
Treatment
Official Title:
Effects of Upper Extremity Rehabilitation Robot and Transcranial Direct Current Stimulation on Upper Extremity Function Among Subjects With Chronic Stroke
Actual Study Start Date :
May 1, 2018
Anticipated Primary Completion Date :
Dec 31, 2019
Anticipated Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Robot and tDCS on-line

Combined transcranial direct current stimulation(tDCS) on-line and upper extremity rehabilitation robot for 10 weeks

Device: Robot and tDCS on-line
Combined transcranial direct current stimulation(tDCS) on-line and upper extremity rehabilitation robot for 5 times a week for 10 weeks

Active Comparator: Robot and tDCS on-line after sham tDCS

Combined sham tDCS and upper extremity rehabilitation robot for 5 weeks, followed by combined tDCS on-line and upper extremity rehabilitation robot for 5 weeks

Device: Robot and tDCS on-line after sham tDCS
Combined sham tDCS and upper extremity rehabilitation robot for 5 times a week for 5 weeks, followed by combined tDCS on-line and upper extremity rehabilitation robot for 5 times a week for 5 weeks

Outcome Measures

Primary Outcome Measures

  1. kinematic data during scale for the assessment [5 weeks after baseline]

    kinematic data during scale for the assessment and rating of ataxia using Trakstar (mean velocity, jerk, smoothness)

Secondary Outcome Measures

  1. kinematic data during scale for the assessment [baseline, 1 weeks after baseline, 5 weeks after baseline, 6 weeks after baseline, 10 weeks after baseline]

    kinematic data during scale for the assessment and rating of ataxia using Trakstar (mean velocity, jerk, smoothness)

  2. Fugl-Meyer Assessment - upper extremity [baseline, 1 weeks after baseline, 5 weeks after baseline, 6 weeks after baseline, 10 weeks after baseline]

    indicator of the level of impairment of upper extremity, with higher scores indicating lower impairment

  3. Wolf Motor Function Test [baseline, 1 weeks after baseline, 5 weeks after baseline, 6 weeks after baseline, 10 weeks after baseline]

    an activity indicator, has 15 items for testing functional ability

  4. Motor activity log [baseline, 1 weeks after baseline, 5 weeks after baseline, 6 weeks after baseline, 10 weeks after baseline]

    Assesses the use of the paretic arm and hand during activities of daily living in hemiparetic stroke patients.

  5. Action reach arm test [baseline, 1 weeks after baseline, 5 weeks after baseline, 6 weeks after baseline, 10 weeks after baseline]

    to assess upper extremity performance (coordination, dexterity and functioning) in stroke recovery

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Hemiplegic patients secondary to first cerebrovascular accidents

  • Onset ≥ 6 months

  • Fugl-Meyer Assessment score ≥ 19

  • Cognitively intact enough to understand and follow the instructions from the investigator

Exclusion Criteria:
  • Severe upper extremity pain that could interfere with rehabilitation therapy

  • Neurological disorders other than stroke that can cause motor deficits

  • Uncontrolled severe medical conditions.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Rehabilitation Center Seoul Korea, Republic of 142884

Sponsors and Collaborators

  • National Rehabilitation Center, Seoul, Korea

Investigators

  • Principal Investigator: Joon-Ho Shin, National Rehabilitation Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Joon-Ho Shin, Team manager, National Rehabilitation Center, Seoul, Korea
ClinicalTrials.gov Identifier:
NCT04005131
Other Study ID Numbers:
  • NRC-2018-01-003
First Posted:
Jul 2, 2019
Last Update Posted:
Jul 2, 2019
Last Verified:
Jun 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Joon-Ho Shin, Team manager, National Rehabilitation Center, Seoul, Korea
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 2, 2019